Related Experiment Video
Updated: May 19, 2026

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
Genome-wide expression profiling of patients with primary open angle glaucoma
Dilek Colak1, Jose Morales, Thomas M Bosley
1Department of Biostatistics Epidemiology and Scientific Computing, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Investigative Ophthalmology & Visual Science
|August 9, 2012
Summary
This study identified a distinct set of blood gene expression signatures in primary open-angle glaucoma (POAG) patients, revealing key molecular pathways involved in POAG pathogenesis.
Area of Science:
- Genomics
- Molecular Biology
- Ophthalmology
Background:
- Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
- Understanding the molecular mechanisms underlying POAG is crucial for developing effective treatments.
Purpose of the Study:
- To identify differentially expressed genes in POAG patients.
- To elucidate gene interaction networks and molecular pathways implicated in POAG development.
Main Methods:
- Genome-wide expression profiling using high-density oligonucleotide microarrays in leukocytes from POAG patients and normal controls.
- Identification of significantly modulated genes based on false discovery rate (FDR) <0.01 and fold change (FC) >1.5.
- Mapping of dysregulated genes to biological processes and pathways.
Main Results:
- A "POAG gene signature" of 563 significantly dysregulated genes (410 upregulated, 153 downregulated) was identified.
- Enriched functions included nucleic acid metabolism, MAPK cascade, apoptosis, and nervous system development.
- Altered canonical pathways included ephrin receptor signaling, ubiquitin proteasome pathway, and G-protein coupled receptor signaling.
Conclusions:
- Blood gene signatures effectively distinguish POAG patients from normal controls.
- Identified molecular pathways offer insights into POAG pathogenesis.
Related Concept Videos
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
